299 results on '"Møller, Holger Jon"'
Search Results
2. The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation
3. Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020
4. Unmeasurable low vitamin D levels caused by a novel, homozygote loss-of-function variant in the group-specific component gene.
5. The association of serum lipid levels with colorectal cancer recurrence
6. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
7. Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial
8. Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease
9. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
10. Fungal translocation measured by serum 1,3‐ß‐D‐glucan correlates with severity and outcome of liver cirrhosis—A pilot study
11. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
12. Neoehrlichia mikurensis – an emerging opportunistic tick‐borne infection in immunosuppressed patients
13. The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis
14. Neoehrlichia mikurensis—An emerging opportunistic tick-borne infection in immunosuppressed patients
15. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)
16. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals
17. Anti-inflammatory liposomes have no impact on liver regeneration in rats
18. Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver
19. Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
20. HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study
21. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment
22. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
23. Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma
24. Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
25. Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness
26. A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
27. Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass
28. The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
29. Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease
30. Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
31. Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness.
32. Patients with Primary Central Nervous System Lymphoma Have High Levels of Soluble Programmed Cell Death Protein 1 in Their Pretherapeutic Cerebrospinal Fluid
33. Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
34. Additional file 1 of The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
35. Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure
36. Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
37. Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
38. Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
39. Macrophage markers and innate immunity in cirrhosis
40. First trimester biomarkers for prediction of gestational diabetes mellitus
41. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Survey Among 17 971 Healthcare and Administrative Personnel at Hospitals, Prehospital Services, and Specialist Practitioners in the Central Denmark Region
42. SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region
43. Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study
44. Macrophage markers do not add to the prediction of liver fibrosis by transient elastography in patients with non-alcoholic fatty liver disease
45. MRI-derived myocardial extracellular volume is closely associated with markers of collagen formation in cirrhosis
46. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute‐on‐chronic liver failure and acute decompensation
47. Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy
48. Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
49. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease
50. Effect of Intravenous 25OHD Supplementation on Bone Turnover and Inflammation in Prolonged Critically Ill Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.